韓國國際生物制藥峰會2012是南韓唯一探討生物制藥,疫苗和生物仿制藥產業和發展的獨特平臺。將于四月16-19日在首爾舉行。此次會議將聚集韓國與國際頂尖生物制藥企業的專家與學者,會著重于探討如何促進生物制藥產品和疫苗的開發與生產。今日韓國的生物和生物仿造藥市場是亞洲發展最快和最有創新能力的市場之一,參會公司包括韓國三星,LG,綠十字等等制藥集團和小型生物藥物研發公司。不要錯過這個難得的機會來和韓國的藥企面對面,以及建立雙邊業務合作關系!
Speakers include:
B G Rhee, President, Green Cross, Korea
Tim Oldham, President, Asia Pacific, Hospira, Australia
Choi Chang Hoon, CEO, ISU Abxis, Korea
Yoo Jin San, President and CEO, PharmAbcine, Korea
Park Heung Rok, Director, ISU Abxis, China
Biologics World Korea 2012 brings you:
• The most targeted platform to meet Korean and international biologics manufacturers
• Case studies and discussions from senior level decision makers who will influence the direction of Korea's biologics industry
• Both strategic and technology-focused biologics development in Korea
Biologics World Korea 2012 Key topics include:
• Opportunities and challenges facing Korea Biologics Industry
• Innovation highlights: Biobetters and novel biologics development in Korea
• Innovation highlights: Vaccine Development in Korea
• Biomanufacturing upstream best practices
• Biomanufacturing downstream best practices
• Operational excellence and PAT
• Crystalballing the future of Korean industry
Contact person: Jasmine Wong
Email: jasmine.wong@imapac.com
Phone number: +65 6493 1598